Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.
about
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyLong-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challengesA systematic review of the safety of lisdexamfetamine dimesylate.Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorderAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamineLisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover StudyTreating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.The use of lisdexamfetamine dimesylate for the treatment of ADHD.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Lisdexamfetamine: A Review in ADHD in Adults.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
P2860
Q26750486-565E3EEB-6EB8-4916-89D6-E3AF4CDE65FFQ26822392-04C97E49-1DEF-4A05-9441-E5F4CAF4A61DQ33755396-19FD8FF2-0C98-4538-A7DD-20BAA4A7C153Q33865315-6FF45D29-5639-448D-A120-B3C5CF0097B1Q33966365-FB42A00D-80AF-4371-9E87-E0A1F09053EFQ34032634-491EE294-CB63-47C3-8B38-20CBC8860127Q34232286-CB27329D-22AF-425C-8619-A0826B92E197Q34518522-3394E507-BA14-492E-BA74-91239E00960DQ35807351-7A01EADD-B46E-4FA0-81FE-CDD906EEB640Q35833310-9B0D5BDC-7879-454C-8FAE-4CB61D82CEFEQ36618017-B0229285-92A6-4D67-97B4-B638C999FC19Q37960505-B1DE148B-DAAF-4E02-BFB2-2AB7DB6BEC1BQ37975550-3665F80E-9D53-4A68-A976-76B5434FFABDQ38221823-00C8FA17-9C8A-43EC-AE95-94B67DB072E0Q38799006-F4546A50-C87F-4796-B395-DF3861FF5FF8Q41312831-D7FABC91-773D-4E78-9228-A01356C8F52AQ47652489-A90267CA-E86F-4DD5-AC0B-ECA7607EE4E7Q57487906-FA06F4E8-D035-42B3-8C31-26CF89CADC78
P2860
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@ast
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@en
type
label
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@ast
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@en
prefLabel
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@ast
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@en
P2093
P2860
P356
P1476
Effects of omeprazole on the p ...... d amphetamine salts in adults.
@en
P2093
James C Ermer
Kenneth C Lasseter
Mary B Haffey
Mary Buckwalter
Patrick Martin
Pinggao Zhang
Robert Homolka
P2860
P356
10.3810/PGM.2009.09.2048
P407
P577
2009-09-01T00:00:00Z